{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T13:01:12Z","timestamp":1784898072830,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SB\/SJF\/2021-22\/01"],"award-info":[{"award-number":["SB\/SJF\/2021-22\/01"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Cell Biology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ceb.2026.102654","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T06:33:39Z","timestamp":1780122819000},"page":"102654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Signaling lipids: An overview of emerging physiological functions"],"prefix":"10.1016","volume":"101","author":[{"given":"Ojal","family":"Saharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathagata","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6132-7574","authenticated-orcid":false,"given":"Siddhesh S.","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ceb.2026.102654_bib1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nrm2335","article-title":"Lipid signalling in disease","volume":"9","author":"Wymann","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOL.0000000000000443","article-title":"Membrane lipids and cell signaling","volume":"28","author":"Sunshine","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.ceb.2026.102654_sref3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2026.102654","article-title":"Signaling lipids: molecular targets for targeted therapies","volume":"91","author":"Chandramouli","year":"2026","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1152\/advan.00088.2006","article-title":"The membrane and lipids as integral participants in signal transduction: lipid signal transduction for the non-lipid biochemist","volume":"31","author":"Eyster","year":"2007","journal-title":"Adv Physiol Educ"},{"key":"10.1016\/j.ceb.2026.102654_bib5","doi-asserted-by":"crossref","first-page":"24431","DOI":"10.1074\/jbc.X116.723791","article-title":"Lipid cell signaling, enzymes, LIPID MAPS, and mediators of inflammation","volume":"291","author":"Dennis","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ceb.2026.102654_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12944-024-02425-1","article-title":"Lipids dysregulation in diseases: core concepts, targets and treatment strategies","volume":"24","author":"Dakal","year":"2025","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ceb.2026.102654_bib7","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem"},{"key":"10.1016\/j.ceb.2026.102654_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ceb.2026.102654_bib9","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.pharmthera.2004.06.003","article-title":"Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation","volume":"103","author":"Hata","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ceb.2026.102654_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/pr.56.3.3","article-title":"Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition","volume":"56","author":"Simmons","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib12","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstrom","year":"2011","journal-title":"Chem Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib13","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-022-00490-x","article-title":"Phosphoinositides as membrane organizers","volume":"23","author":"Posor","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib14","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1152\/physrev.00006.2016","article-title":"The inositol Trisphosphate\/Calcium signaling pathway in health and disease","volume":"96","author":"Berridge","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bbalip.2012.08.016","article-title":"Formation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells","volume":"1831","author":"Vance","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ceb.2026.102654_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ceb.2026.102654_bib17","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/febs.16809","article-title":"Phosphatidic acid: from biophysical properties to diverse functions","volume":"291","author":"Zhou","year":"2024","journal-title":"FEBS J"},{"key":"10.1016\/j.ceb.2026.102654_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrm.2017.107","article-title":"Sphingolipids and their metabolism in physiology and disease","volume":"19","author":"Hannun","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.12703\/P6-109","article-title":"S1P signaling: new therapies and opportunities","volume":"6","author":"Gonzalez-Cabrera","year":"2014","journal-title":"F1000Prime Rep"},{"key":"10.1016\/j.ceb.2026.102654_bib20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ceb.2026.102654_bib21","first-page":"25","article-title":"Biological effects of lysophospholipids","volume":"160","author":"Rivera","year":"2008","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.ceb.2026.102654_bib22","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.biochem.73.011303.073731","article-title":"Lysophospholipid receptors: signaling and biology","volume":"73","author":"Ishii","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.ceb.2026.102654_bib23","first-page":"607","article-title":"Review of the endocannabinoid system","volume":"6","author":"Lu","year":"2021","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.ceb.2026.102654_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","article-title":"Cannabinoids and the expanded endocannabinoid system in neurological disorders","volume":"16","author":"Cristino","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ceb.2026.102654_bib25","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1124\/pr.112.006387","article-title":"Chemical probes of endocannabinoid metabolism","volume":"65","author":"Blankman","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev-arplant-042817-040440","article-title":"The oxylipin pathways: biochemistry and function","volume":"69","author":"Wasternack","year":"2018","journal-title":"Annu Rev Plant Biol"},{"key":"10.1016\/j.ceb.2026.102654_sref27","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101276","article-title":"Oxylipin profiling for clinical research: current status and future perspectives","volume":"95","author":"Parchem","year":"2024","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ceb.2026.102654_bib28","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cell.2014.09.035","article-title":"Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects","volume":"159","author":"Yore","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ceb.2026.102654_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13735","article-title":"Fatty acid esters of hydroxy fatty acids: a potential treatment for obesity-related diseases","volume":"25","author":"Li","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2020.101053","article-title":"Understanding FAHFAs: from structure to metabolic regulation","volume":"79","author":"Brejchova","year":"2020","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ceb.2026.102654_sref31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41589-024-01827-7","article-title":"The measurement, regulation and biological activity of FAHFAs","volume":"21","author":"Tan","year":"2025","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib32","doi-asserted-by":"crossref","first-page":"8798","DOI":"10.1021\/jacs.9b00045","article-title":"Discovery of FAHFA-containing triacylglycerols and their metabolic regulation","volume":"141","author":"Tan","year":"2019","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ceb.2026.102654_bib33","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/s41586-022-04787-x","article-title":"ATGL is a biosynthetic enzyme for fatty acid esters of hydroxy fatty acids","volume":"606","author":"Patel","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ceb.2026.102654_bib34","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1074\/jbc.RA119.012145","article-title":"AIG1 and ADTRP are endogenous hydrolases of fatty acid esters of hydroxy fatty acids (FAHFAs) in mice","volume":"295","author":"Erikci Ertunc","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ceb.2026.102654_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nchembio.2051","article-title":"AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs","volume":"12","author":"Parsons","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib36","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1021\/acs.biochem.6b00565","article-title":"Branched fatty acid esters of hydroxy fatty acids are preferred substrates of the MODY8 protein carboxyl ester lipase","volume":"55","author":"Kolar","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.ceb.2026.102654_sref37","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1038\/s41467-024-48220-5","article-title":"Inflammation causes insulin resistance in mice via interferon regulatory factor 3 (IRF3)-mediated reduction in FAHFA levels","volume":"15","author":"Yan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ceb.2026.102654_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107972","article-title":"Branched and linear fatty acid esters of hydroxy fatty acids (FAHFA) relevant to human health","volume":"231","author":"Riecan","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ceb.2026.102654_bib39","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1111\/febs.16266","article-title":"Specialized pro-resolving mediators: biosynthesis and biological role in bacterial infections","volume":"289","author":"Jordan","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.ceb.2026.102654_sref40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41569-023-00984-x","article-title":"Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease","volume":"21","author":"Fredman","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ceb.2026.102654_bib41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ceb.2026.102654_bib42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.ceb.2026.102654_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.838782","article-title":"Formation, signaling and occurrence of specialized pro-resolving lipid mediators-what is the evidence so far?","volume":"13","author":"Schebb","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ceb.2026.102654_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ceb.2026.102654_bib45","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bph.14587","article-title":"Lipid mediators in immune regulation and resolution","volume":"176","author":"Gilroy","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ceb.2026.102654_sref46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177808","article-title":"The overlooked complexity of resolution: specialized pro-resolving mediators in focus","volume":"1002","author":"Jha","year":"2025","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ceb.2026.102654_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0001-2014","article-title":"Macrophage proresolving mediators-the when and where","volume":"4","author":"Dalli","year":"2016","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ceb.2026.102654_bib48","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1074\/jbc.M609212200","article-title":"Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation","volume":"282","author":"Sun","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ceb.2026.102654_bib49","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ceb.2026.102654_bib50","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1073\/pnas.0402531101","article-title":"Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress","volume":"101","author":"Mukherjee","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ceb.2026.102654_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.ceb.2026.102654_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165783","article-title":"Alzheimer\u2019s disease and specialized pro-resolving lipid mediators: do MaR1, RvD1, and NPD1 show promise for prevention and treatment?","volume":"21","author":"Miyazawa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ceb.2026.102654_sref53","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1021\/acs.chemrev.3c00701","article-title":"Lysophosphatidylserine: a signaling lipid with implications in human diseases","volume":"124","author":"Chakraborty","year":"2024","journal-title":"Chem Rev"},{"key":"10.1016\/j.ceb.2026.102654_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00232-020-00133-2","article-title":"The Lysophosphatidylserines-An emerging class of signalling lysophospholipids","volume":"253","author":"Shanbhag","year":"2020","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib55","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.chembiol.2021.01.008","article-title":"Fatty acid chain length drives lysophosphatidylserine-dependent immunological outputs","volume":"28","author":"Khandelwal","year":"2021","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.ceb.2026.102654_bib56","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1021\/acs.biochem.0c00349","article-title":"Mapping the neuroanatomy of ABHD16A, ABHD12, and lysophosphatidylserines provides new insights into the pathophysiology of the human neurological disorder PHARC","volume":"59","author":"Singh","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ceb.2026.102654_sref57","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108157","article-title":"Identification of ABHD6 as a lysophosphatidylserine lipase in the mammalian liver and kidneys","volume":"301","author":"Chakraborty","year":"2025","journal-title":"J Biol Chem"}],"container-title":["Current Opinion in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955067426000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955067426000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:05:29Z","timestamp":1784894729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955067426000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"alternative-id":["S0955067426000426"],"URL":"https:\/\/doi.org\/10.1016\/j.ceb.2026.102654","relation":{},"ISSN":["0955-0674"],"issn-type":[{"value":"0955-0674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signaling lipids: An overview of emerging physiological functions","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ceb.2026.102654","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102654"}}